Literature DB >> 19817963

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup.

Tamaki Yamada1, Mitsuru Fukatsu, Sadao Suzuki, Tsuneya Wada, Takashi Yoshida, Takashi Joh.   

Abstract

BACKGROUND AND AIM: The question of whether fatty liver might predict impaired fasting glucose or type 2 diabetes mellitus in a longitudinal manner was assessed in Japanese subjects undergoing a health checkup.
METHODS: A total of 12 375 individuals (6799 men and 5576 women) without hyperglycemia or type 2 diabetes mellitus in 2000 and participating in 2005 were included. Multiple logistic regression analyses were performed for both sexes, adjusted for age, body mass index, elevated blood pressure or hypertension, family history of diabetes mellitus, alcohol drinking and smoking.
RESULTS: Impaired fasting glucose and type 2 diabetes mellitus were newly diagnosed in 7.6% and 1.0% of men and 3.8% and 0.5% of women, respectively, within the 5-year period. The prevalence of newly diagnosed impaired fasting glucose and type 2 diabetes mellitus was significantly higher in the participants with fatty liver than without fatty liver in both sexes. Fatty liver adjusted for the other factors was thus a risk factor for impaired fasting glucose and/or type 2 diabetes mellitus in both sexes (men odds ratio [OR] 1.91, 95% confidence interval [CI] 1.56-2.34 and women OR 2.15, 95% CI 1.53-3.01). The impact of fatty liver was stronger among the participants with a lower body mass index (men OR 0.92, 95% CI 0.86-0.99 and women OR 0.90, 95% CI 0.81-0.99, for one increment of body mass index).
CONCLUSION: Fatty liver is an independent risk factor for impaired fasting glucose and type 2 diabetes mellitus, having a stronger impact in those Japanese with a lower body mass index undergoing a health checkup.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817963     DOI: 10.1111/j.1440-1746.2009.05998.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  47 in total

1.  Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.

Authors:  Yasushi Imamura; Hirofumi Uto; Yasunari Hiramine; Kaori Hosoyamada; Sho Ijuin; Shiro Yoshifuku; Hironori Miyahara; Shigeho Maenohara; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-10-31       Impact factor: 7.527

2.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 3.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

5.  Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes.

Authors:  Ki-Chul Sung; Sun H Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

Review 6.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

7.  Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Osamu Yoshida; Mitsuhito Koizumi; Shin Yamamoto; Takao Watanabe; Yasunori Yamamoto; Yoshio Tokumoto; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-03-12       Impact factor: 7.527

8.  Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.

Authors:  Teruki Miyake; Masashi Hirooka; Osamu Yoshida; Shinya Furukawa; Teru Kumagi; Mitsuhito Koizumi; Shin Yamamoto; Taira Kuroda; Eiji Arimitsu; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-06-24       Impact factor: 7.527

9.  Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality.

Authors:  Altan Onat; Günay Can; Ayşem Kaya; Tuğba Akbaş; Fatma Özpamuk-Karadeniz; Barış Şimşek; Hakan Çakır; Hüsniye Yüksel
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

10.  Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.

Authors:  Kil Woo Lee; Ki Bae Bang; Eun Jung Rhee; Heon Ju Kwon; Mi Yeon Lee; Yong Kyun Cho
Journal:  Clin Mol Hepatol       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.